Introduction of complete mesocolic excision with central vascular ligation as standardized surgical treatment for colon cancer in Greece. Results of a pilot study and bi-institutional cooperation.

INTRODUCTION

Complete mesocolic excision (CME) is generally accepted as state of the art in colon cancer surgery. However, the long-term impact of CME has not been systematically examined. Therefore cohort studies might be a possible way to clarify any differences between conventional resections and CME. Following bilateral cooperation between the Department of Surgery/University Hospital of Erlangen and the 1 Surgical Department of the General Hospital of Nikaia/Piraeus, including teaching activities for introduction of CME, a cohort study was performed, considering surgical quality criteria and clinical outcome.

MATERIAL AND METHODS

All patients with colon carcinomas (CME group, = 31) referred to the 1 Surgical Department of General Hospital, Nikaia/Piraeus, Greece for surgery from January 2012 to December 2013 were prospectively analyzed and compared with patients who underwent conventional surgery for colon cancer between January 2008 and December 2011 (non-CME group, = 35). Patients' follow-up was at least 48 months.

RESULTS

There were significantly better results in terms of lymph node yield (CME group: 29.6 vs. non-CME group: 17.85; < 0.001) and lymph node ratio (LNR) (CME group: 0.12 vs. non-CME group: 0.24; < 0.001) and recurrence-free survival in favor of the CME group (CME group: = 0 vs. non-CME group: = 5) without any increase in surgical morbidity (CME group: = 6 vs. non-CME group: = 11; = 0.10).

CONCLUSIONS

Complete mesocolic excision appears to offer a superior oncological result without any increase of postoperative morbidity and mortality. Furthermore, CME represents a surgical technique which can be established in a surgical department after previous teaching without increasing the postoperative complication rate.